Trial Profile
Risk of Major Adverse Cardiovascular Events Among Users of Naldemedine Compared With Other Medications Used for Opioid Induced Constipation in Adult Patients With Chronic Non-Cancer Pain in a Healthcare Claims Database
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2022
Price :
$35
*
At a glance
- Drugs Naldemedine (Primary) ; Lubiprostone; Naloxegol
- Indications Constipation
- Focus Adverse reactions
- Sponsors Shionogi
- 28 Feb 2022 Planned End Date changed from 1 Nov 2025 to 1 Nov 2030.
- 28 Feb 2022 Planned primary completion date changed from 1 Nov 2025 to 1 Nov 2030.
- 02 Apr 2019 Status changed from not yet recruiting to recruiting.